Table 3 The association between coffee type and digestive cancer within the UK Biobank

From: Coffee consumption by type and risk of digestive cancer: a large prospective cohort study

  

Most common type of coffee used

 
 

Non-use

Decaffeinated

Instant

Ground

Other types

Heterogeneity pa

n

104,465

69,363

201,912

82,865

6674

 

Oesophageal cancer

 Cases

74

53

166

46

7

 

 Unadjusted HR

1.00

0.91 (0.64, 1.30)

1.03 (0.78, 1.36)

0.76 (0.52, 1.09)

1.43 (0.66, 3.11)

0.18

 Adjusted HR

1.00

1.27 (0.82, 1.98)

1.12 (0.78, 1.59)

1.08 (0.78, 1.59)

1.58 (0.56, 4.41)

0.63

Oesophageal squamous cell carcinoma

 Cases

15

14

36

8

<5

 

 Unadjusted HR

1.00

1.21 (0.58, 2.52)

1.12 (0.61, 2.05)

0.65 (0.27, 1.54)

2.04 (0.46, 8.92)

0.54

 Adjusted HR

1.00

1.27 (0.46, 3.51)

1.16 (0.52, 2.58)

1.03 (0.38, 2.83)

4.17 (0.89,19.46)

0.87

Oesophageal adenocarcinoma

 Cases

55

36

122

35

6

 

 Unadjusted HR

1.00

0.83 (0.54, 1.26)

1.01 (0.73, 1.39)

0.77 (0.50, 1.18)

1.64 (0.71, 3.83)

0.60

 Adjusted HR

1.00

1.33 (0.79, 2.24)

1.18 (0.78, 1.80)

1.17 (0.69, 1.97)

1.65 (0.50, 5.41)

0.63

Gastric cancer

 Cases

65

29

117

31

<5

 

 Unadjusted HR

1.00

0.57 (0.37, 0.88)

0.83 (0.61, 1.12)

0.59 (0.38, 0.90)

0.93 (0.34, 2.56)

0.13

 Adjusted HR

1.00

0.88 (0.52, 1.48)

1.04 (0.70, 1.52)

0.87 (0.52, 1.45)

0.90 (0.22, 3.76)

0.69

Small intestinal cancer

 Cases

14

11

35

12

<5

 

 Unadjusted HR

1.00

1.04 (0.47, 2.30)

1.18 (0.63, 2.20)

1.06 (0.49, 2.29)

2.20 (0.50, 9.70)

0.82

 Adjusted HR

1.00

1.70 (0.65, 4.41)

1.07 (0.46, 2.51)

1.16 (0.42, 3.15)

4.39 (0.93, 20.8)

0.34

Colon cancer

 Cases

320

220

650

223

22

 

 Unadjusted HR

1.00

0.90 (0.76, 1.07)

0.95 (0.83, 1.09)

0.86 (0.72, 1.02)

1.05 (0.68, 1.62)

0.51

 Adjusted HR

1.00

0.95 (0.78, 1.17)

0.91 (0.77, 1.07)

0.84 (0.68, 1.04)

1.21 (0.73, 2.02)

0.50

Rectal and anal cancer

 Cases

176

103

371

119

8

 

 Unadjusted HR

1.00

0.77 (0.61, 0.99)

0.99 (0.83, 1.19)

0.83 (0.66, 1.05)

0.69 (0.34, 1.42)

0.06

 Adjusted HR

1.00

0.83 (0.62, 1.11)

0.95 (0.76, 1.18)

0.80 (0.60, 1.05)

0.56 (0.20, 1.53)

0.39

Liver cancer

 Cases

48

23

80

26

<5

 

 Unadjusted HR

1.00

0.62 (0.37, 1.02)

0.77 (0.54, 1.11)

0.67 (0.41, 1.07)

0.95 (0.29, 3.06)

0.72

 Adjusted HR

1.00

0.82 (0.45, 1.49)

0.91 (0.59, 1.41)

0.84 (0.47, 1.50)

0.58 (0.07, 4.24)

0.92

Hepatocellular carcinoma

 Cases

26

11

37

11

<5

 

 Unadjusted HR

1.00

0.54 (0.27, 1.10)

0.66 (0.40, 1.09)

0.52 (0.25, 1.05)

1.17 (0.28, 4.95)

0.71

 Adjusted HR

1.00

0.59 (0.25, 1.37)

0.51 (0.28, 0.93)

0.47 (0.20, 1.08)

Too small

0.53

Intrahepatic bile duct carcinoma

 Cases

16

9

33

12

<5

 

 Unadjusted HR

1.00

0.72 (0.32, 1.64)

0.95 (0.52, 1.73)

0.92 (0.43, 1.94)

0.95 (0.12, 7.17)

0.91

 Adjusted HR

1.00

0.97 (0.38, 2.43)

1.27 (0.63, 2.55)

1.46 (0.63, 3.35)

1.48 (0.19,11.54)

0.91

Gallbladder and extrahepatic bile duct carcinoma

 Cases

14

25

34

18

<5

 

 Unadjusted HR

1.00

2.28 (1.18, 4.39)

1.11 (0.60, 2.08)

1.57 (0.78, 3.16)

2.17 (0.78, 3.16)

0.06

 Adjusted HR

1.00

2.44 (1.10, 5.38)

1.33 (0.63, 2.82)

1.84 (0.77, 4.44)

Too small

0.11

Pancreatic cancer

 Cases

81

46

178

69

<5

 

 Unadjusted HR

1.00

0.72 (0.50, 1.03)

1.00 (0.77, 1.31)

1.04 (0.75, 1.43)

0.93 (0.37, 2.30)

0.17

 Adjusted HR

1.00

0.66 (0.43, 1.03)

0.95 (0.69, 1.29)

0.99 (0.68, 1.45)

0.81 (0.25, 2.60)

0.31

All digestive cancers

 Cases

784

507

1614

536

53

 

 Unadjusted HR

1.00

0.84 (0.75, 0.94)

0.96 (0.88, 1.04)

0.84 (0.75, 0.93)

1.03 (0.78, 1.36)

0.007

 Adjusted HR

1.00

0.95 (0.83, 1.09)

0.97 (0.87, 1.07)

0.89 (0.78, 1.02)

1.03 (0.72, 1.47)

0.61

  1. The model contains age at baseline, sex, deprivation, education, BMI, alcohol, smoking, fruit and vegetable intake, tea intake, physical activity and comorbidities at baseline (including high cholesterol, hypertension, diabetes, angina, myocardial infarction, stroke, peptic ulcer disease, hepatitis, cirrhosis and gallstones)
  2. aP-value for likelihood ratio test comparing cancer risk by coffee type (decaffeinated, instant, ground and other types)